Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Endocrine
|
April 21, 2016
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype
N M Albiger, D Regazzo, B Rubin, et al.
Journal of Endocrinological Investigation
|
October 10, 2007
Pegvisomant in acromegaly: why, when, how
A Colao, G Arnaldi, P Beck-Peccoz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study
M Filopanti, L Olgiati, G Mantovani, et al.
Journal of Endocrinological Investigation
|
November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study
A Faggiano, P Ferolla, F Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statement
G Arnaldi, A Angeli, A B Atkinson, et al.
Journal of Endocrinological Investigation
|
November 21, 2017
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)
E Sbardella, A M Isidori, G Arnaldi, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Endocrine
|
April 21, 2016
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype
N M Albiger, D Regazzo, B Rubin, et al.
Journal of Endocrinological Investigation
|
October 10, 2007
Pegvisomant in acromegaly: why, when, how
A Colao, G Arnaldi, P Beck-Peccoz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study
M Filopanti, L Olgiati, G Mantovani, et al.
Journal of Endocrinological Investigation
|
November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study
A Faggiano, P Ferolla, F Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statement
G Arnaldi, A Angeli, A B Atkinson, et al.
Journal of Endocrinological Investigation
|
November 21, 2017
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)
E Sbardella, A M Isidori, G Arnaldi, et al.
Page
of 8